AIMS: The purpose of this study was to verify the impact on the number and characteristics of coronary invasive procedures for acute coronary syndrome (ACS) of two hub centers with cardiac catheterization facilities, during the first month of lockdown following the COVID-19 pandemic. MATERIALS AND METHODS: Procedural data of ACS patients admitted between 10 March and 10 April 2020 were compared with those of the same period of 2019. RESULTS: We observed a 23.4% reduction in ACS admissions during 2020, with a decrease for both ST-elevation myocardial infarction (STEMI) (-5.6%) and non-ST-elevation myocardial infarction (-34.5%), albeit not statistically significant (P = 0.2). During the first 15 days of the examined periods, the reduction in ACS admissions reached 52.5% (-25% for STEMI and -70.3% for non-ST-elevation myocardial infarction, P = 0.04). Among STEMI patients, the rate of those with a time delay from symptoms onset longer than 180 min was significantly higher during the lockdown period (P = 0.01). Radiograph exposure (P = 0.01) was higher in STEMI patients treated in 2020 with a slightly higher amount of contrast medium (P = 0.1) and number of stents implanted (P = 0.1), whereas the number of treated vessels was reduced (P = 0.03). Percutaneous coronary intervention procedural success and in-hospital mortality were not different between the two groups and in STEMI patients (P NS for all). CONCLUSION: During the early phase, the COVID-19 outbreak was associated with a lower rate of admissions for ACS, with a substantial impact on the time delay presentation of STEMI patients, but apparently without affecting the in-hospital outcomes.
AIMS: The purpose of this study was to verify the impact on the number and characteristics of coronary invasive procedures for acute coronary syndrome (ACS) of two hub centers with cardiac catheterization facilities, during the first month of lockdown following the COVID-19 pandemic. MATERIALS AND METHODS: Procedural data of ACS patients admitted between 10 March and 10 April 2020 were compared with those of the same period of 2019. RESULTS: We observed a 23.4% reduction in ACS admissions during 2020, with a decrease for both ST-elevation myocardial infarction (STEMI) (-5.6%) and non-ST-elevation myocardial infarction (-34.5%), albeit not statistically significant (P = 0.2). During the first 15 days of the examined periods, the reduction in ACS admissions reached 52.5% (-25% for STEMI and -70.3% for non-ST-elevation myocardial infarction, P = 0.04). Among STEMI patients, the rate of those with a time delay from symptoms onset longer than 180 min was significantly higher during the lockdown period (P = 0.01). Radiograph exposure (P = 0.01) was higher in STEMI patients treated in 2020 with a slightly higher amount of contrast medium (P = 0.1) and number of stents implanted (P = 0.1), whereas the number of treated vessels was reduced (P = 0.03). Percutaneous coronary intervention procedural success and in-hospital mortality were not different between the two groups and in STEMI patients (P NS for all). CONCLUSION: During the early phase, the COVID-19 outbreak was associated with a lower rate of admissions for ACS, with a substantial impact on the time delay presentation of STEMI patients, but apparently without affecting the in-hospital outcomes.
Authors: Ivy Lynn Mak; Eric Yuk Fai Wan; Teenie Kwan Tung Wong; Wendy Woo Jung Lee; Esther Wai Yin Chan; Edmond Pui Hang Choi; Celine Sze Ling Chui; Mary Sau Man Ip; Wallace Chak Sing Lau; Kui Kai Lau; Shing Fung Lee; Ian Chi Kei Wong; Esther Yee Tak Yu; Cindy Lo Kuen Lam Journal: Public Health Rev Date: 2022-04-27
Authors: Stéphane Rinfret; Israth Jahan; Kevin McKenzie; Nandini Dendukuri; Kevin R Bainey; Samer Mansour; Madhu Natarajan; Luiz F Ybarra; Aun-Yeong Chong; Simon Bérubé; Robert Breton; Michael J Curtis; Josep Rodés-Cabau; Amlani Shy Shoaib; Alireza Bagherli; Warren Ball; Alan Barolet; Hussein K Beydoun; Neil Brass; Albert W Chan; Franco Colizza; Christian Constance; Neil P Fam; François Gobeil; Tinouch Haghighat; Steven Hodge; Dominique Joyal; Hahn Hoe Kim; Sohrab Lutchmedial; Andrea MacDougall; Paul Malik; Steve Miner; Kunal Minhas; Jason Orvold; Donald Palisaitis; Brendan Parfrey; Jean-Michel Potvin; Geoffrey Puley; Sam Radhakrishnan; Marco Spaziano; Jean-François Tanguay; Ram Vijayaraghaban; John G Webb; Rodney H Zimmermann; David A Wood; James M Brophy Journal: CJC Open Date: 2021-05-12
Authors: Mats de Lange; Ana Sofia Carvalho; Óscar Brito Fernandes; Hester Lingsma; Niek Klazinga; Dionne Kringos Journal: Int J Environ Res Public Health Date: 2022-03-08 Impact factor: 3.390